Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 24;9(2):601.
doi: 10.3390/jcm9020601.

Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19)

Affiliations

Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19)

Asami Anzai et al. J Clin Med. .

Abstract

The impact of the drastic reduction in travel volume within mainland China in January and February 2020 was quantified with respect to reports of novel coronavirus (COVID-19) infections outside China. Data on confirmed cases diagnosed outside China were analyzed using statistical models to estimate the impact of travel reduction on three epidemiological outcome measures: (i) the number of exported cases, (ii) the probability of a major epidemic, and (iii) the time delay to a major epidemic. From 28 January to 7 February 2020, we estimated that 226 exported cases (95% confidence interval: 86,449) were prevented, corresponding to a 70.4% reduction in incidence compared to the counterfactual scenario. The reduced probability of a major epidemic ranged from 7% to 20% in Japan, which resulted in a median time delay to a major epidemic of two days. Depending on the scenario, the estimated delay may be less than one day. As the delay is small, the decision to control travel volume through restrictions on freedom of movement should be balanced between the resulting estimated epidemiological impact and predicted economic fallout.

Keywords: emerging infectious diseases; imported case; migration; quarantine; travel.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Number of confirmed cases outside China by date of report. The bars measure the number of cases reported each day between 13 January and 6 February 2020. The black bars represent infections that are likely to have occurred in China while the grey bars indicate infections that are likely to have occurred outside China.
Figure 2
Figure 2
Observed and expected number of cases diagnosed outside China by date of report. Observed cases (dots) include those infected in China. An exponential growth curve was fitted to the observed data from 27 January 2020. The dashed lines represent the 95% confidence interval on and after 28 January 2020.
Figure 3
Figure 3
Probability of a major epidemic with various levels of transmissibility and traced contact. (A) The solid lines represent the probability of a major epidemic in the counterfactual scenario, i.e., based on the expected number of cases diagnosed in Japan. Dashed lines represent the probability of a major epidemic in the presence of travel volume reductions, calculated using the number of traced and untraced cases was 6 in total in Japan from Day 58 to Day 67. Contact tracing leading to isolation was assumed at three different levels: 10%, 30%, and 50%. (B) The vertical axis represents the reduced probability of a major epidemic due to travel volume reduction. The horizontal axis shows the proportion of cases traced, adopting the same scenarios as panel A.
Figure 4
Figure 4
Delay in the time to a major epidemic gained by travel volume reduction. The median delay is shown for Japan, using relative reduction in the probability of a major epidemic. The vertical axis represents the time delay to a major epidemic (in days), and the horizontal axis represents the proportion of contacts traced. Each shaped dot represents different values of the basic reproduction number.

References

    1. World Health Organization Novel Coronavirus—China, 2020. [(accessed on 11 February 2020)]; Available online: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
    1. World Health Organization Novel Coronavirus (2019-nCoV) Situation Report-21, 2020. [(accessed on 11 February 2020)]; Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Center for Disease Central and Prevention 2019 Novel Coronavirus, Wuhan, China, 2020. [(accessed on 11 February 2020)]; Available online: https://www.cdc.gov/coronavirus/2019-nCoV/summary.html.
    1. Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2001468. (In Press) - DOI - PMC - PubMed
    1. Chan F.J., Yuan S., Kok K.H., To K.K., Chu H., Yang J., Xing F., Liu J., Yip C.C., Poon R.W., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020 doi: 10.1016/S0140-6736(20)30154-9. (In Press) - DOI - PMC - PubMed